Chemotherapy with or without abdominal mist for colon cancer spread
Part of Cancer, Digestive system clinical trials.
This trial tests whether adding a special chemotherapy mist sprayed directly into the abdomen helps people with colon cancer that has spread to the lining of the belly. It compares this approach to standard chemotherapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are able to care for yourself and are up and about at least half of the day (ECOG 0-2).
- You have colon cancer that has spread to the lining of your abdomen and cannot be removed with surgery.
- You have not had chemotherapy for advanced cancer before, but you may have had it after surgery if it ended more than 6 months ago.
- You must have had a surgery to look inside your belly within the last 4 weeks to confirm the spread.
- You do not have a blockage in your bowel that cannot be treated with medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
This trial tests a new way to give chemotherapy by spraying it into the belly during a minimally invasive surgery. It is for people whose colon or rectal cancer has spread inside the belly (peritoneal metastasis) but not to other organs.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This Phase 2 study tests whether spraying chemotherapy into the abdomen (through a small procedure) after colon cancer surgery can lower the chance the cancer comes back. It is meant for people with high-risk tumor features but who have had surgery and have no proven relapse yet.
This trial tests a treatment called PIPAC, where chemotherapy is sprayed as a mist into the abdomen during a minimally invasive surgery. It is for people whose pancreatic cancer has spread to the lining of the belly, and aims to see if this approach is safe and helpful.
This trial tests a new way to deliver chemotherapy directly into the abdomen as a pressurized spray, using a drug called mitomycin. It is for people with appendix or colorectal cancer that has spread to the lining of the abdomen and cannot be removed by surgery.
Hear when a new Peritoneal Metastases From Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.